Overall, obesity is linked to higher risk and progression of MS, influencing relapse rates, brain volume decline, neuroinflammation, hormone levels (leptin and adiponectin), and gut microbiota. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.